6CW Stock Chart & Stats
€0.07
<€0.01(4.26%)
At close: 4:00 PM EST
€0.07
<€0.01(4.26%)
Day’s Range― - ―
52-Week Range€0.05 - €0.79
Previous CloseN/A
Volume0.00
Average Volume (3M)1.89K
Market Cap
€70.15M
Enterprise Value€116.28M
Total Cash (Recent Filing)€5.20M
Total Debt (Recent Filing)€64.96M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Aug 06, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding270,549,930
10 Day Avg. Volume3,171
30 Day Avg. Volume1,886
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-28.04
Price to Sales (P/S)1.15
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)€34.20M
Bulls Say, Bears Say
Bulls Say
Stable Gross MarginConsistent low-40% gross margins indicate the core products retain reasonable unit economics. Over a multi-month horizon this margin provides a foundation for profitability if revenue stabilizes or operating costs are reduced, supporting long-term recovery options.
Diverse Product Portfolio & ChannelsA multi-category product set and mixed DTC plus wholesale/retail distribution reduces single-channel dependency. Structurally this supports cross-selling, distribution resilience and multiple routes to recover revenue over several months to years as demand patterns shift.
Established Charlotte’s Web BrandAn established consumer brand in the hemp/CBD wellness space is a durable intangible asset that aids retailer placement, consumer trust and pricing power. Brand equity can lower customer acquisition costs and support margin recovery if operations normalize.
Bears Say
Shrinking Revenue TrendSteep, sustained revenue contraction erodes scale economics and makes fixed-cost absorption harder. Over 2–6 months this trend limits ability to leverage gross margins, constrains reinvestment, and increases pressure to restructure or seek new channels to stabilize top line.
Persistent Negative Cash FlowOngoing operating cash burn and negative free cash flow create reliance on external financing or asset sales. This structural liquidity gap limits capacity to invest in marketing, product development, or inventory, and raises dilution or solvency risk over the medium term.
Weak Balance Sheet & Negative EquityNegative equity combined with sizeable debt signals elevated solvency and refinancing risk. Structurally, this impairs financial flexibility, increases cost of capital, and heightens the risk that operational setbacks force dilutive financing or asset disposals to remain solvent.
Charlotte's Web Holdings News
6CW FAQ
What was Charlotte's Web Holdings (OTC)’s price range in the past 12 months?
Charlotte's Web Holdings (OTC) lowest stock price was €0.05 and its highest was €0.79 in the past 12 months.
What is Charlotte's Web Holdings (OTC)’s market cap?
Charlotte's Web Holdings (OTC)’s market cap is €70.15M.
When is Charlotte's Web Holdings (OTC)’s upcoming earnings report date?
Charlotte's Web Holdings (OTC)’s upcoming earnings report date is Aug 06, 2026 which is in 29 days.
How were Charlotte's Web Holdings (OTC)’s earnings last quarter?
Currently, no data Available
Is Charlotte's Web Holdings (OTC) overvalued?
According to Wall Street analysts Charlotte's Web Holdings (OTC)’s price is currently Overvalued.
Does Charlotte's Web Holdings (OTC) pay dividends?
Charlotte's Web Holdings (OTC) does not currently pay dividends.
What is Charlotte's Web Holdings (OTC)’s EPS estimate?
Charlotte's Web Holdings (OTC)’s EPS estimate is -0.02.
How many shares outstanding does Charlotte's Web Holdings (OTC) have?
Charlotte's Web Holdings (OTC) has 270,549,930 shares outstanding.
What happened to Charlotte's Web Holdings (OTC)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Charlotte's Web Holdings (OTC)?
Currently, no hedge funds are holding shares in DE:6CW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Charlotte's Web Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
642.22%
12-Months-Change
Fundamentals
Return on Equity
-2065.45%
Trailing 12-Months
Asset Growth
-34.56%
Trailing 12-Months
Company Description
Charlotte's Web Holdings (OTC)
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress relief, immune support, and post-exercise recovery, as well as easy-to-use capsules, topical CBD creams, and lotions. They also offer specialized products for pets. These offerings are available under recognized brands including Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids, such as CBD, cannabichromene, cannabigerol, and cannabinol, alongside beneficial terpenes, flavonoids, and other hemp compounds. Distribution occurs through various channels, including brick-and-mortar retail locations, healthcare providers, and direct-to-consumer sales via their online platform. The company is committed to advancing cannabinoid research; its CW Labs science division collaborates with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 as Stanley Brothers Holdings Inc., the company rebranded to Charlotte's Web Holdings, Inc. in July 2018 and is headquartered in Denver, Colorado.
6CW Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized several transformative, strategic positives — a balance-sheet‑clearing BAT transaction with fresh capital, federal Medicare pilot eligibility (Substance Access BEI) allowing full‑spectrum CBD access into accountable care channels, meaningful clinical progress via DeFloria's Phase II clearance, substantial cost reductions (SG&A down ~21% YoY and ~44.5% over two years), and improved operating loss and margin runways. These positives are tempered by ongoing regulatory uncertainty (including a potential November 2026 hemp provision that could severely constrain the market), persistent net losses (Q4 net loss $11.4M; full‑year net loss ~$29.7M), a nonrecurring $1.3M inventory charge that depressed reported margins, and liquidity dependence on shareholder approval of the BAT transaction. On balance, the call conveyed constructive momentum and multiple high‑impact catalysts that materially improve the company’s strategic position, while acknowledging meaningful near‑term risks and the gradual timing of revenue realization from Medicare pilots.View all DE:6CW earnings summariesTechnical Analysis
Options Prices
Currently, No data available
---